Abstract Aims/hypothesis: In non-diabetic people, insulin levels in the liver are two-fold higher than those in the systemic circulation. In contrast, patients with type 1 diabetes have similar hepatic and systemic insulin levels because insulin is administered peripherally. The aim of this study was to compare the effects of systemic (SI) and preportal (PI) insulin administration on energy, glucose and protein metabolism in chronic insulin-dependent ketosisprone diabetic dogs. Materials and methods: We applied glucose-controlled insulin infusion, indirect calorimetry and stable isotope and radioisotope techniques to measure energy, protein and glucose metabolism. We maintained near-normoglycaemia at identical levels under both study conditions for 20 h. Results: SI was associated with lower oxygen consumption (130±13 vs 161±8 ml/min), CO 2 production (99±10 vs 130±8 ml/min), respiratory quotient (0.76±0.02 vs 0.81±0.01) and energy expenditure (870±90 vs 1089±60 kcal/24 h) (p<0.05 for all differences). PI increased the respiratory quotient from the insulin-deprived state, whereas SI did not. Glucose kinetics were similar for SI and PI, whereas leucine oxidation (36±4 vs 54±5 μmol kg
Introduction
Intensive insulin treatment by means of multiple daily injection or continuous subcutaneous infusion by pump is now routinely used to treat patients with type 1 diabetes. These approaches substantially improve glycaemic control and reduce microvascular complications in type 1 and type 2 diabetes [1, 2] but may result in variable amounts of weight gain [3, 4] and increased hypoglycaemic episodes [5] . Improvement of HbAlc from 12.9±0.9% to 9.6±0.6% resulted in 2.4±0.8 kg weight gain (p<0.05) after 2 months of intensive insulin therapy in patients with type 1 diabetes [3] . Even with perfect glycaemic control, the employed peripheral route of insulin administration is different from normal physiology in that there is no first-pass hepatic insulin catabolism which normally results in steady-state systemic insulin concentrations being only half that in the portal circulation [6] . The question remains to be answered whether systemic vs portal administration of insulin has any differential impact on metabolic control in diabetes, and whether the possible drawbacks mentioned above of rigorous insulin treatment may be related to the systemic route of insulin administration.
Previous studies have demonstrated that peripheral administration of insulin reduces resting metabolic rate in those with type 1 diabetes [7, 8] but it remains to be determined whether the alterations in energy metabolism are similar irrespective of the route of insulin administra-tion. Insulin has different effects on the synthesis of different hepatic proteins [9] and a link between synthetic activity, energy metabolism and insulin in the liver may be of importance. These questions cannot be answered in humans by controlled portal vs systemic studies. Therefore, the current study to elucidate the effects of pre-portal vs systemic insulin administration on protein and energy metabolism was performed in insulin-dependent diabetic dogs, maintained in a normoglycaemic state. Because of the established effects of systemic insulin administration on energy expenditure [7, 8] , the resting metabolic rates were also investigated. The same animals served as controls when they were in an insulin-deprived, hyperglycaemic state for metabolic rate measurements.
Materials and methods

Animals
The specific aims and design of this study were approved by the Animal Ethics Committee of the Ministry of Nutrition, Agriculture, Forests and Fisheries of Mecklenburg-Vorpommern, Schwerin, Germany (Reg. No: VI462a 7221/3-TV-026/91). Animals were obtained from Versuchstierzucht Groβ-Börnecke, D-39435 Groβ-Börnecke, Sachsen-Anhalt, Germany. Ten male, long-term experimentally diabetic ASDI dogs (the result of crossbreeding German shepherd and Australian Dingo) weighing 23±1 kg were studied at an age of 26±5 months.
Diabetes was induced by subtotal pancreatectomy (90% of estimated organ weight removed) in combination with intra-pancreatico-arterial infusion of 2 mg/kg streptozotocin, as previously reported [10] . The animal model has been proved to be canine C-peptide-negative. The stools showed no steatorrhoea. At the time of the first experiment, duration of diabetes was 5±3 months. Daily metabolic control was achieved by means of two pelleted meals and of three subcutaneous injections of regular insulin (Actrapid HM; 40 IU/ml; Novo Nordisk Pharma, Mainz, Germany; average dose 1.4±0.1 IU kg
), which were adjusted to avoid ketonuria and to maintain stable body weight and glycaemic excursions between 4 and 12 mmol/l.
Preparation for the experimental procedure From 4 weeks before the start of the study, the dogs were regularly accustomed to free-standing in a Pavlov harness for the duration of the planned procedure. Three weeks before the start of the study, a portal venous infusion catheter (0.040×0.085-in. silicone tubing [0.1×0.2 cm]; Intracath, Toronto, ON, Canada) was implanted in the diabetic animals through a midline laparatomy, as previously detailed [11] . The external ends of the catheters were kept in the pocket of a canvas jacket that was worn by the animals throughout the study period. Catheters were flushed twice weekly with heparinised saline (100 IU/ml; Biochemie, Vienna, Austria). During the week before the first metabolic study, the dogs were trained three times a day to breathe through a self-manufactured mouth mask. An inflated cuff around the mask guaranteed complete passage of breath air on the route requested. Breathing under these conditions was well tolerated by all the dogs.
Experimental groups Eight out of the total of ten animals served in paired pre-portal (PI) vs systemic (SI) insulin infusion studies, and six of these acted as pre-controls for insulin withdrawal (IW). The order of the two or three, respectively, different trials in a given animal, was randomly assigned. To avoid additional surgical procedures in the same animal we did not perform liver biopsies in these dogs during insulin deprivation and therefore liver protein synthesis rates were not measured during insulin deprivation. The protein synthesis measurements only include paired studies involving two treatment approaches: preportal and systemic insulin administration.
Infusates For glucose-controlled insulin infusion (GCII), Actrapid insulin was diluted with 0.154 mol/l NaCl supplemented with 10% v/v homologous serum to give a final concentration of 240 mU/ml. D- [6- 3 H]Glucose from Amersham International (Little Chalfont, UK; specific activity 1184 GBq/mmol), was used. The entire tracer dose to be applied in one experiment was diluted with 50 ml saline.
Sodium [1- The chemical, isotopic and optical purities of these compounds were confirmed prior to use. Solutions were prepared under sterile conditions and were shown to be free of bacteria and pyrogens before use.
Protocol One week before the metabolic studies the dogs were put on a controlled diet consisting of 350 g pellets (Noblesse; Paragon Petcare, Nettetal-Leuth, Germany) + 150 g canned dog food (BEWI DOG, Südlohn, Germany) (composition: carbohydrate 44%, fat 26%, protein 26% and ash 4%), which were given twice daily (at 06:00 and 18:00 hours).
On the day before the experiment, blood glucose was maintained between 6 and 10 mmol/l by means of individually adapted s.c. insulin doses given at 06:00, 11:00 and 16:00 hours, and the dogs received their last meal at 10:00 hours.
In the PI and SI studies, the dogs were taken to the laboratory at 18:00 hours the evening before the experiment. A cannula was inserted into one cephalic vein to take blood samples for blood glucose monitoring, and an infusion catheter was inserted into one saphenous vein with its tip in the lower caval vein. Background saline infusion (0.25 ml/min) was commenced; all other infusions were connected to this line (except insulin in the PI tests) and were applied by means of separate pumps (Perfusor E; B. Braun-Melsungen, Melsungen, Germany) according to protocol (see below). GCII was also started at this time, either via the implanted portal catheter (PI) or via the saphenous catheter (SI). GCII was performed on the basis of plasma glucose determinations at intervals of 10 or 20 min, respectively, and subsequent adjustment of insulin infusion rate according to a modified empirical algorithm employing standard parameters as presented before [12] . Thus, normoglycaemic steady state was established and maintained throughout until 15:30 hours on the following day (i.e. the day of the experiment).
At 04:00 hours on the experimental day, the animals were allowed a 15-min walk outside the laboratory to relieve themselves. Thereafter, a central-venous catheter was inserted via an external jugular vein for additional blood samplings. At 04:30 hours respiration was monitored three times for about 7-8 min. Two one-way valves permitted the animals to inhale room air directly and to exhale via a tube into the metabolic cart (Datex Deltatrac, Metabolic Monitor; Instrumentarium Corp., Helsinki, Finland), which was run in the respiration mode. Also, for later MS analysis of CO 2 , breath was sampled via this breath tube into 20 ml vacutainers.
The [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]leucine tracer infusion was started at 05:00 hours. At this time (i.e. 19 h after the last meal), enteral absorption appeared to be completed [13] , and no appreciable further change of feedback-controlled insulin infusion rate was to be expected (cf. Fig. 1 ). Priming doses of L-[1- ) was maintained for 10 h at a rate of 0.5 ml/min.
A primed constant infusion of D- H]glucose (122 kBq/kg prime; 1,029 Bq kg −1 min −1 infusion dose) was applied from 11:00 hours for 240 min at a rate of 0.208 ml/min.
Mixed-venous blood samples were taken at 04:50, 05:00, 07:00, 08:00, 09:00, 10:00, 11:00, 12:00, 13:00, 14:00 and 15:00 hours to estimate labelled leucine, ketoisocaproate (KIC) and labelled plasma proteins, albumin and fibrinogen. Blood to analyse metabolites was taken at 05:00, 10:00 and 15:00 hours. To determine the specific Metabolic cart data (carbon dioxide production ( _ VCO 2 ); oxygen uptake ( _ V O 2 ), breath volume (V ), energy expenditure in kcal/24 h) were monitored at 1-h intervals between 10:00 and 15:00 hours. Blood gases were analysed from central venous blood at 12:00 hours, immediately after the related metabolic cart monitoring, using the AVL 990S Automatic Blood Gas System (Graz, Austria).
At 09:00 hours a muscle biopsy was taken from the vastus lateralis muscle under local anaesthesia (0.8 ml lidocaine 2%; Braun Melsungen, Germany). At 15:00 hours, general anaesthesia was induced (0.5 g Pentobarbital; United Pharmaceutical Works, Prague, Czech Republic) and additional biopsies were taken from the same muscle of the other lower leg and from the liver via median mini-laparotomy. All tissue samples were frozen immediately in liquid nitrogen.
In a given dog, sequential experiments (IW where appropriate vs PI vs SI) were performed after complete wound healing at an interval of approximately 1 month. In the respective repeats, the biopsies were taken from the same sites at an appropriate distance from the original biopsy points, except the control experiments (IW) where liver biopsies were not taken.
In the IW, SI and PI protocols, central venous pH was 7.31±0.01, 7.35±0.01 and 7.37±0.01, respectively, showing the tendency of acidosis only in the insulin-deprived animals (p<0.01); PCO2 was 4.91±0.24, 4.85±0.20 and 4.60±0.10 mmHg, respectively, ruling out hyperventilation and no other variables of acid-base metabolism differed from those in a non-diabetic control group.
White blood cell counts on the day of the experiment did not differ between sequential trials (10±1·[×109]/1 vs 9±1· [×109]/1, NS). In all animals, the haematocrit, which declined during a given experiment from 0.41±0.01 to 0.37±0.01, restored to the pre-experimental level during the 1-month interval between experiments.
In the control tests (IW), the dogs underwent the same procedure except that they did not receive any insulin after 14:00 hours the day before the experiment. Their plasma glucose was 11.0±1.4 mmol/l at 19:00 hours. They were taken to the laboratory at 04:00 hours on the experimental day.
Analysis of samples Plasma concentrations of glucose were measured throughout the experiment, using established automated enzymatic techniques (Beckman Analyzer, Fullerton, CA, USA).
Plasma β-hydroxybutyrate, lactate and pyruvate were measured by standard enzymatic-spectrophotometric procedures as detailed previously [11, 14] . The activity of tritiated glucose was measured after deproteination and lyophilisation of plasma and re-dissolution of the extracts as described previously [15] . 13 C enrichment in breath samples was analysed by isotopic mass spectrometry (IRMS) [16] .
Plasma KIC was extracted from plasma and measured as its quinoxalinol-trimethylsilyl derivative using chemical ionisation [17] . Tissue fluid amino acids were extracted from muscle and liver tissue using perchloric acid and were analysed as their t-butyldimethylsilyl ester derivative [18] . Plasma and tissue fluid enrichment levels of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C] leucine were determined by gas chromatography/mass spectrometry as previously described [19] . The amino acids from the plasma samples were isolated by cation exchange chromatography and dried down. All standards and samples were derivatised with N-methyl-N (t-butyldimethyl)-trifluoroactamide+1% t-butyldimethylchlorosilane in acetonitrile (Regis Technologies, Morton Grove, IL, USA) at room temperature overnight. The derivatives were injected onto a 30 m×0.25 mm×0.25 μm film DB5MS column (J and W Chromatography, Folsom, CA, USA) in a gas chromatograph oven at constant flow of helium (1.1 ml/min). The injector temperature was 250°C. The column was heated with a gradient programme as follows: 120°C for 1 min; increase to 210°C at 25°C/min, to 225°C at 25°C/min, to 265°at 10°C/min, to 300°C at 25°C/min and finally to 325°C at 10°C/min and held for 2 min. Under electron ionisation, ion mass was monitored at m/z 200, 201, 302, 303 and 304 for leucine using a Hewlett Packard 5,972 MSD (Hewlett Packard, Avondale, CA, USA) [20] .
Mixed liver tissue proteins and muscle proteins were analysed by gas chromatography/combustion/isotopic mass spectrometry after acid precipitation and hydrolysis as reported elsewhere [16] . The hydrolysed muscle and liver proteins were derivatised as their N-heptafluorobutyrylmethyl esters. The amino acids were separated in a DB5-MS 0.5-μm film fused silica column and oven temperature was set as previously described [16] . Helium was used as the carrier gas. The mass spectrometry analysis and the calculation of atom per cent excess was performed as previously described [16] . Plasma albumin and fibrinogen were isolated and purified, and their isotopic enrichment was measured as previously described [21] .
To determine serum amino acid concentrations, samples were deproteinised by means of 80 mmol/l sulphosalicylic acid. After supplementation with 25 μmol/l norleucine as an internal standard and centrifugation, 40 μl of the supernatant was applied to the amino acid analyser LKB 4151 Alpha Plus (Pharmacia, Stockholm, Sweden). Analytical quality was regularly proven by means of calibration against artificial amino acid mixtures (accuracy ≥90%, C v ≤5%).
NEFAs were analysed using the Wako kit (NEFA C; Wako Pure Chemical Industries, Osaka, Japan) which utilises the acylation of coenzyme-A.
Radioimmunoassays of plasma insulin and pancreatic glucagon have been described elsewhere [11] .
Calculations The specific activity data obtained between 500 and 600 min according to the experimental protocol (13:20 to 15:00 hours) were used to calculate the flux rates of glucose according to Steele's equation [22] . The means±SEM of the average flux rates during these five 20-min intervals are presented.
Indirect calorimetry ( _ VCO 2 , _ VO 2 , V, energy expenditure) and calculated RQ were measured at intervals of 1 h between 10:00 and 15:00 hours [2, 23] . The means±SEM of the averages of these six sets of data are presented.
Mean values of isotopic enrichment at the plateau (values from 12:00 to 15:00 hours minus basal measurements at 04:50 and 05:00 hours) were used for all calculations of amino acid kinetics. Plateau values of isotopic enrichment of leucine and KIC, respectively, were verified from the zero slope of a time-dependent plot between 12:00 and 15:00 hours. Equations used for calculation of leucine kinetics are discussed elsewhere [24, 25] .
The fractional synthesis rate (FSR) of mixed muscle protein was calculated from the increment in [1-
13 C]leucine enrichment of mixed muscle protein between the two muscle biopsies, using leucyl-tRNA enrichment as the precursor pool [18, 19, 26] . A similar approach was used for the calculation of FSR of liver tissue protein [23] . The FSRs of albumin and fibrinogen were calculated from the slopes of isotopic enrichment of albumin and fibrinogen as previously reported [21] . Since in a previous study [23] we have found plasma Statistical analysis The means±SEM of measured values or of averages over indicated intervals are presented. Paired Student's t test was used to assess the significance of differences at the p<0.05 level in SI vs PI experiments. For comparison of these experiments with the control tests on IW, a non-paired t test was applied. The SPSS Program, version 3.1 (SPSS, Chicago, IL, USA) was employed.
Results
Glucose metabolism, insulin and glucagon
Plasma glucose concentrations and GCII rates administered in the SI and PI experiments are shown in Fig. 1 . At the beginning of GCII at 19:00 hours the evening before the experiments (3 h after the last subcutaneous insulin administration), the animals were moderately hyperglycaemic (7-9 mmol/l). Near-normoglycaemia was reached via either route within 4 h of GCII and was maintained for the following 16 h. The steady-state glycaemia levels did not differ between the PI and SI protocols (5.1±0.3 vs 5.5±0.3 mmol/l; NS). To maintain these levels, approximately twice the insulin dose had to be applied via the preportal route (PI 54±4 vs SI 27±2 mU kg
; p<0.01) which, however, resulted in slightly but significantly lower average plasma insulin levels than SI ( Fig. 2; p<0.05) .
In contrast, in the control group withdrawn from insulin (IW), the plasma insulin levels were generally close to the detection limit of the assay [11] and thus significantly lower than in the GCII trials (Fig. 2) . Accordingly, starting with similar plasma glucose levels the afternoon before, these animals were hyperglycaemic throughout the experimental day (05:00 hours: 27.3±1.8 mmol/l; p<0.001 vs SI and PI, cf. Fig. 1 ).
Endogenous glucose production (Ra-glucose) was significantly lower in insulin-infused dogs (SI and PI) and the metabolic clearance rates (MCR) were higher than in the insulin-deprived animals (IW, p<0.01). Again, there was no appreciable difference between the SI and PI protocols (Table 1) .
Plasma glucagon levels were consistently lower in dogs receiving insulin compared to those on the IW protocol (p<0.05) with no appreciable difference between PI and SI (Fig. 2) .
Substrate concentrations
The diabetic dogs receiving insulin (PI and SI) had consistently lower plasma levels of NEFA, glycerol, and β-hydroxybutyrate than the insulin-deprived dogs (p<0.05) Average of six measurements 20 min apart *p<0.01 vs SI and PI but the concentrations were not influenced by the route of insulin infusion. Lactate and pyruvate did not differ between the experimental groups ( Table 2 ).
Plasma amino acids
Comparing the prehepatic with the posthepatic route of insulin administration in the GCII protocols, the only remarkable difference was that the alanine levels were higher in PI than in SI (p<0.05).
In the IW group, plasma levels of Asp, Glu, Val, Ile, Leu, Orn and Lys tended to be higher, but those of Ser, Asn, Gln, Gly, Ala and Arg tended to be lower than in the two groups on GCII (SI and PI). However, only part of these differences reached the level of statistical significance (Table 3) .
Whole-body leucine metabolism and FSRs of proteins
In the well-insulinised, normoglycaemic state during GCII, PI led to slightly higher rates of leucine flux and oxidation than SI and to slightly lower mixed muscle protein FSR (Table 4 ). The FSR of liver tissue proteins, albumin and fibrinogen, however, were significantly higher during preportal insulin administration (Fig. 3) . Thus, there was no related difference in the overall non-oxidative leucine disappearance rate (NOLD, Table 4 ). As shown above (cf . Table 3 ), no significant difference could be assessed in the plasma leucine levels either.
On insulin withdrawal (IW), however, the elevated plasma leucine levels were paralleled by significant elevations in the rates of leucine flux and oxidation but not of NOLD, and-under these conditions-mixed muscle protein synthesis appeared only marginally reduced (Table 4) .
Indirect calorimetry PI administration resulted in significantly higher energy expenditure than SI. The RQ was also significantly higher following PI than during SI administration (p<0.05). _ VO 2 , The data are presented as the means±SEM of measurements at 05:00 hours (0 min), 10:00 hours (300 min) and 15:00 hours (600 min) *p<0.05 vs IW _ VCO 2 and energy expenditure were lower in PI and SI than in IW (p<0.05). In contrast, RQ were similar during IW and SI (p>1.0) (Fig 4) .
Discussion
It was previously reported that insulin-dependent, ketosisprone diabetic dogs [11] are characterised by enhanced appearance rate but reduced metabolic clearance rate of glucose. These animals also demonstrated increased leucine flux but reduced RQ. In the current study we further investigated the effect of different routes of insulin administration (pre-portal vs systemic) on energy metabolism and synthesis rates of muscle and liver proteins. To maintain similar blood glucose and glucose kinetics, the insulin requirement was higher when insulin was administered pre-portally. Systemic insulin administration caused a reduction in the synthesis rate of liver proteins (albumin and fibrinogen as well as tissue proteins). It also resulted in lower energy expenditure, leucine oxidation and RQ. Of note, the RQ were similar when insulin was withdrawn and when it was administered systemically. Therefore, systemic insulin administration caused greater reduction in leucine oxidation and energy expenditure than when insulin was administered pre-portally.
The results from this animal study cannot be directly translated to the clinical situation in patients with type 1 diabetes. However, the differences in energy metabolism demonstrated in the current animal experiments have many potential clinical implications. Firstly, the pre-portal administration caused an increase in RQ unlike systemic insulin administration, indicating higher carbohydrate oxidation. As has been previously reported in people with type 1 diabetes [7, 8] , insulin withdrawal caused an increased energy expenditure and insulin administration resulted in reduction of energy expenditure. However, the current study demonstrated that the route of administration has a significant effect on the magnitude of fall in energy expenditure. The systemic administration of insulin caused an approximately 30% reduction in energy expenditure whereas pre-portal administration caused only a 13% reduction in energy expenditure. In paired analysis the systemic administration, as opposed to pre-portal administration, was associated with an average 20% lower energy expenditure (average 219 kcal/day) which can theoretically result in 0.7 kg fat accretion per month. However, the current study was performed in the fasted state while the post-prandial state represents the greater part of the day. It is possible that the response of the energy metabolism to different routes of insulin administration may differ between the fasted and the fed state. Post-prandial changes in energy metabolism, however, are a smaller component than the resting energy expenditure [27] . We further propose that the results from the current animal study suggests that in human diabetic patients the current method of administering insulin via a peripheral route has the potential to cause weight gain as observed during intensive insulin treatment [3] .
The cause of this substantially lower energy expenditure following systemic insulin administration is not entirely clear from the current study. A previous human study indicated that glucagon has thermogenic effect in humans [28] and increased glucagon levels following insulin-deprivation is mostly responsible for increased energy expenditure in type 1 diabetic patients during insulin deprivation [8] . Plasma glucagon levels substantially decreased during both systemic (average 47%) and pre-portal insulin administration (average 35%). The reduction in glucagon is likely to have contributed to the fall in energy expenditure, but it is not clear whether in systemic vs pre-portal administration the differences in energy expenditure can be explained on the basis of the different magnitudes in the fall of glucagon levels. The relative concentrations of glucagon and insulin are reported to have important metabolic consequences [29] . The relative increase in insulin concentration in the liver during pre-portal insulin administration may increase leucine oxidation. Our previous studies demonstrated that decarboxylation of ketoisocaproate is enhanced by insulin [20] . Increased insulin in the liver can also potentially enhance many other energetically costly processes as shown in the case of protein synthesis. Reduction in gluconeogenesis, an energy consuming biochemical process that increases during insulin deficiency, is proposed as a cause of insulin-induced fall in energy expenditure [30] . However, in the current study there is no evidence to suggest a lesser reduction in gluconeogenesis following pre-portal insulin administration. On the contrary, the higher circulating alanine following pre-portal insulin delivery found in this investigation and also reported previously from our laboratory [11] , even after peritoneal administration of insulin [31] , suggests that gluconeogenesis was lower because less alanine was consumed for gluconeogenesis. Another potential reason is that leucine flux, which represents protein turnover [25] , was significantly reduced by systemic insulin treatment whereas no significant change was noted with pre-portal insulin administration. We also noted that pre-portal insulin administration resulted in higher RQ, indicating increased oxidation of carbohydrates as a fuel.
Previous studies have demonstrated that whole-body protein turnover (leucine flux) accounts for approximately 25% of resting metabolic rate [32] . A greater reduction of leucine flux, thus may be an independent factor for the reduction in energy expenditure following systemic insulin infusion. Leucine oxidation was also reduced to a greater extent during systemic insulin infusion, which might also have contributed to the lower energy expenditure found in diabetic dogs during systemic insulin administration. Amino acid catabolism results in ammonia formation and then, through the ornithine cycle, in urea production, which is an energy-consuming reaction. The greater reduction in leucine oxidation also may have contributed to the lower energy expenditure in diabetic dogs during systemic insulin administration. The increased synthesis rates of liver tissue proteins and albumin occurring with pre-portal insulin administration may have contributed to higher energy expenditure because protein synthesis is an energy-consuming reaction.
It is intriguing that systemic insulin administration resulted in a greater reduction in leucine flux, a measure of whole-body protein turnover. The main difference between the delivery of insulin via the systemic and pre-portal routes is that the former is associated with an estimated 50% decrease in insulin levels in hepatic circulation. In contrast the insulin levels are lower in hepatic circulation during systemic insulin delivery because of a 13±2% mesenteric extraction [33] . Based on regional studies it is clear that amino acids, rather than insulin, are the key regulator of splanchnic protein breakdown [34] . In contrast, insulin is a key regulator of muscle protein turnover [35, 36] . It is therefore likely that during systemic delivery the relatively higher steady-state systemic levels of insulin have caused suppression of muscle protein breakdown. A reduced breakdown of proteins in the peripheral tissues may reduce the ability to repair tissues. It remains to be determined whether such changes have any impact on chronic complications, especially involving microvascular complications.
We anticipated that the main differences in protein metabolism would be in the liver. The higher hepatic to systemic insulin ratio with higher hepatic liver insulin levels during pre-portal administration of insulin has pronounced effects on the synthesis of liver proteins. A higher synthesis both of tissue proteins and of export proteins in the liver was noted in this study during pre-portal vs systemic insulin administration. Previous studies where we infused insulin peripherally had no effect on liver tissue protein or albumin synthesis in a pig model [23] and nor was splanchnic protein synthesis elevated. This lack of stimulation of liver protein synthesis by systemic insulin administration suggests a relation to the simultaneous increase in peripheral and hepatic insulin levels as noted in the previous study [23] . In contrast, when in the current study insulin was delivered pre-portally resulting in relatively lower peripheral insulin levels there was a stimulation of synthesis of liver proteins. These results suggest that systemic insulin administration may alter the normal physiology of liver protein synthesis. Since most liver-derived proteins have profound systemic effects the potential impact of our study requires careful follow-up. The recent advances in proteomic approaches [37] may allow us to determine whether glycaemic control in patients with type 1 diabetes with systemic insulin administration alters the synthesis of any liver-derived plasma proteins.
We conclude that substantial differences in energy and protein metabolism occur in diabetic dogs when insulin is administered to achieve a similar glycaemic control via the systemic and pre-portal routes. Pre-portal insulin administration is associated with a smaller fall in energy expenditure. RQ is increased only by pre-portal insulin and not by systemic insulin administration, indicating a greater carbohydrate oxidation with pre-portal insulin delivery. In the long term, these changes may result in less weight gain than when insulin is administered systemically. Higher leucine flux, leucine oxidation and synthesis of liver proteins may be responsible for higher energy expenditure during pre-portal insulin administration in dogs. It remains to be determined whether the effect of systemic vs preportal insulin administration on liver protein synthesis is global or selective for certain proteins. Since many proteins originating from the liver have major functional impacts in dealing with defence against infection or stress reaction and inflammatory responses, etc., the pre-portal insulin administration of insulin may offer advantages.
